Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsNew strategies for human papillomavirus-based cervical screeningCancer diagnostic classifiers based on quantitative DNA methylationRecommendations on screening for cervical cancerA comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population-PREDICTORS 4Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy resultsA PCR-based microwell-plate hybrid capture assay for high-risk human papillomavirus.A DNA methylation classifier of cervical precancer based on human papillomavirus and human genesHPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methodsCervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 TestsCytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions.Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men.Comparing the performance of six human papillomavirus tests in a screening populationHuman Papillomavirus Laboratory Testing: the Changing ParadigmHPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media.The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screeningDisagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme.A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancersCredentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection.Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.Understanding HPV tests and their appropriate applications.Cervical cancer screening: on the way to a shift from cytology to full molecular screening.Nucleic acid-based assays for the detection of high-risk human papillomavirus: a technical review.FHACT: the FISH-based HPV-associated cancer test that detects nonrandom gain at four genomic loci as biomarkers of disease progression.Role of E6/E7 mRNA test in the diagnostic algorithm of HPV-positive patients showing ASCUS and LSIL: clinical and economic implications in a publicly financed healthcare system.Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions.Role of quantitative p16INK4A mRNA assay and digital reading of p16INK4A immunostained sections in diagnosis of cervical intraepithelial neoplasia.Genotype distribution characteristics of high-risk human papillomaviruses in women from Shanghai, China.
P2860
Q24198236-A4EF5790-76EB-4D30-B435-7BF22E3DCBC1Q26851699-0CF109BD-D73D-40B0-85A8-396A01BF77D1Q27012960-599221C9-D00A-4B83-9395-3DEB14E37091Q28282866-D4BDF588-8995-4810-A839-9C034AF3D260Q30276176-7E42C950-7209-4DB7-A354-B61133AC88B8Q33574454-8AFD8303-2328-419F-9F1E-4F4424EEE8BAQ34298145-D0557371-0B97-4042-82AB-D24A7D9481EEQ34459447-8650B357-DA74-4CF7-84CF-C85D011657CDQ34531028-3A6BEA81-B856-472C-8A10-B13585436834Q34535660-F43A5D41-D9B0-4F2B-92D5-5277FFAE5D9CQ34608714-1FA64B97-8A4A-4438-BCFE-E4ACECF2986CQ34637954-097DCD62-F945-4032-AFBC-3E869B6312FCQ35193205-8333AF0C-AFFE-4662-B73C-A0F6873AF781Q35852900-A1C05F75-73F9-4C09-B81F-351E3607C7BDQ35932079-6740EAF4-E035-443C-A190-45D4D0D14B2FQ36023019-9716C492-0931-458F-BCA6-DE3DC1DDE6DDQ36046119-E410E0E4-54D9-4F95-A507-F7548942C2D3Q36183493-C4680E5A-D798-4E97-9A00-539FFBE13ACEQ36190228-0334218F-4354-4002-87F9-1379E019D5B5Q36514226-F4BB56BB-D49D-40CF-B3B1-83C370464B9BQ36663594-3378979F-DF62-4881-9D1A-0E344262123EQ36675236-3F4CAD43-4808-4099-AA3A-62A4D0BDB1AEQ36856284-2D14FC9B-830B-4959-81E6-62796C5B541CQ37036177-63F86CEF-0CB6-47DC-B132-A92D1BE34A86Q37218627-05888A2E-F347-478E-9F25-50A8918A4F3AQ37470374-6A622366-3346-4EC5-BA11-A60CAA1746DCQ37496183-D3CCD1ED-CC93-41C5-8EE4-E96CB79D4AA2Q37516596-D17156D3-FAB2-4992-9753-4F637E946CF4Q37671558-3169FA18-41B3-433B-B104-17FFC32A2872Q37706679-16D29F7E-C89D-447B-8D42-CD0223F0BB0FQ37725467-3946D4EB-2541-4B5B-85C2-E2BE60C22FA4Q38123772-75E90393-2836-4983-B652-E78AC574EFEAQ38133612-80113C53-5B47-43DB-A79A-C0598417BAE2Q38180277-347CE53F-62E7-43D8-8FEC-582449DA033EQ38221059-1F8E3025-2E2A-4B02-AA47-1C9524679287Q38259453-34940672-4FB0-46E3-A0C9-8009FA742CC8Q39124983-58179C4D-437F-45AF-B504-220C0C1EDFC3Q39177983-42A37415-C267-40D3-92AF-3099D8CC99DEQ40199758-DB1434BA-8B39-476E-9A7C-C664E152FEFFQ40337385-E1D260AA-6650-4BCE-ABCB-3984D68C8013
P2860
Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Comparison of seven tests for ...... mears: the Predictors 2 study.
@ast
Comparison of seven tests for ...... mears: the Predictors 2 study.
@en
type
label
Comparison of seven tests for ...... mears: the Predictors 2 study.
@ast
Comparison of seven tests for ...... mears: the Predictors 2 study.
@en
prefLabel
Comparison of seven tests for ...... mears: the Predictors 2 study.
@ast
Comparison of seven tests for ...... mears: the Predictors 2 study.
@en
P2093
P2860
P356
P1476
Comparison of seven tests for ...... smears: the Predictors 2 study
@en
P2093
Anne Szarewski
Christine Bergeron
Corrina Wright
Deirdre Lyons
George Terry
Jack Cuzick
Julie McCarthy
Lesley Ashdown-Barr
Louise Cadman
P2860
P304
P356
10.1128/JCM.00181-12
P407
P577
2012-03-14T00:00:00Z